Fanta H, Kurz M, Marx J, Zotti A
Klin Monbl Augenheilkd. 1983 Dec;183(6):471-6. doi: 10.1055/s-2008-1054986.
The clinical efficacy of Efemoline eyedrops [fluourometholone (0.1%) + tetryzoline (0.25%)] and of fluorometholone 0.1% was investigated in a double-blind controlled clinical trial in 35 patients (63 eyes) in treatment of the upper bulbus area and postoperatively after surgery for cataract, glaucoma and strabismus. Both drugs were effective inflammation inhibitors. The superiority of fluorometholone + tetryzoline over fluorometholone was evident: subjective symptoms improved much more quickly. No tendency toward elevation of intraocular pressure was found. The combined preparation was compatible and produced no side-effects.
在一项双盲对照临床试验中，对35例患者（63只眼）使用艾氟莫林滴眼液[氟米龙（0.1%）+四氢唑啉（0.25%）]和0.1%氟米龙治疗眼球上部区域以及白内障、青光眼和斜视手术后的情况进行了研究。两种药物都是有效的炎症抑制剂。氟米龙+四氢唑啉比氟米龙更具优势：主观症状改善更快。未发现眼压升高的趋势。复方制剂耐受性良好，无副作用。
